ABT vs STEM · P/E 25, rev $44.33B vs rev $144.6M
Abbott Laboratories (ABT) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. STEM currently screens at market cap $82.1M.
Not investment advice. Open the ABT and STEM stock pages for the full models.
Not investment advice.